Video 10 Sep 2024 Ausbiz | Interview with John Van Der Wielen Orthocell Chairman, John Van Der Wielen spoke with ausbiz host Nadine Blayney about the Company’s expansion into Canada with dental… Orthocell
Video 09 Sep 2024 Proactive | Interview with John Van Der Wielen Following the Company's announcement last week confirming the first sales of Striate+ in Canada, Orthocell's Chairman John Van Der Wielen spoke… Orthocell
Media 06 Sep 2024 The Australian | Orthocell’s collagen-membrane dental-regeneration product Striate+ debuts in Canada Orthocell's entry to to the Canadian market with the first sales of Striate+ has been reported in The Australian in… Orthocell
Company News 06 Sep 2024 First Sales of Striate+™ in New and Significant Market of Canada Orthocell has today announced global distribution partner BioHorizons has recorded a fast transition to first sales of Striate+™ in the… Orthocell
Company News 05 Sep 2024 Petra Capital Research Report | September 2024 Petra Capital has released a research report valuing #Orthocell (ASX:OCC) at A$1.28 per share. The report summarises Orthocell’s revenue growth, and… Orthocell
Company News 29 Jul 2024 Orthocell submits Singapore Regulatory Application for Striate+™ Orthocell has announced its application to market and sell its leading guided bone and tissue repair product Striate+™ in Singapore,… Orthocell
Media 24 Jul 2024 Proactive | Interview with Paul Anderson Following the announcement that Orthocell is accelerating its global market expansion of Striate+™ and Remplir™, Managing Director Paul Anderson spoke… Orthocell
Company News 24 Jul 2024 Orthocell Accelerates Global Market Expansion of Striate+™ and Remplir™ With Seven New Regulatory Applications either in progress or planned Orthocell has announced the accelerated market expansion of Striate+™ and Remplir™, with seven regulatory applications either in progress or planned… Orthocell
Company News 11 Jul 2024 Orthocell Receives Regulatory Approval to Commence Sales of Striate+™ in Canada Orthocell has received a Medical Device Licence from Health Canada, allowing the commencement of sales of its market leading dental… Orthocell
Media 10 Jul 2024 The Australian Business Review | Investors are all ears as Orthocell’s nerve and tissue solutions deliver record revenue News of Orthocell's record-breaking quarterly and full year revenue has been published in a Special Report in The Australian Business… Orthocell
